# Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma

> **NCT06508463** · PHASE1 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 21 (estimated)

## Conditions studied

- Peripheral T Cell Lymphoma
- Relapsed Peripheral T-Cell Lymphoma
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Anaplastic Large Cell Lymphoma
- Mycosis Fungoides
- Relapsed Anaplastic Large Cell Lymphoma
- Relapsed Mycosis Fungoides

## Interventions

- **PROCEDURE:** Biopsy
- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Biopsy
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Positron Emission Tomography
- **BIOLOGICAL:** Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
- **PROCEDURE:** Single Photon Emission Computed Tomography
- **BIOLOGICAL:** Cemiplimab
- **BIOLOGICAL:** Ipilimumab

## Key facts

- **NCT ID:** NCT06508463
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-05
- **Primary completion:** 2028-12-31
- **Final completion:** 2032-04-01
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06508463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06508463, "Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06508463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*